E&E News, July 8, 2022: The sight of rubber surfaces on playgrounds concerns Dr. Diana Zuckerman, “because as president for the National Center for Health Research she has testified in front of multiple municipal and even state governments about the toxic chemicals that can lurk on those playground surfaces.” They look very pretty and feel spongy if a child falls, but the evidence shows the toxic chemicals in these surfaces can be harmful to children.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
These machines to help people breathe were recalled a year ago. Many still use them
Los Angeles Times, June 23, 2022: CPAP, BiPAP, and other ventilators made by Philips that help people stay alive were recalled more than a year ago. But patients haven’t been informed and others can’t live without them unless there is a replacement device that they can afford. FDA is now pressuring Philips to replace them.
Read More »Costly Alzheimer’s treatment is spreading around the world, with virtually no science to back it up
Stat News, June 1, 2022: Thousands of patients have undergone a type of “shockwave therapy” called transcranial pulse stimulation (TPS) for Alzheimer’s disease and other conditions. The Neurolith device costs patients thousands of dollars but isn’t proven to work. It is not FDA approved for use in the U.S. but Boris Kawliche, a Florida psychiatrist, has been offering TPS at Brandon TMS and Psychiatry clinic since November. Snake oil or treatment?
Read More »STAT Report : The need for speed and safety: A primer on the FDA’s drug approval pathways
This STAT report provides an excellent primer on FDA’s drug approval pathways, and the controversies about whether patients can be harmed when FDA standards get too lose. Dr. Diana Zuckerman describes the need for the FDA Commissioner to restore the public’s trust.
Read More »Will the FDA change how it vets drugs following the Alzheimer’s debacle?
Nature, May 13, 2022: Nearly a year after the FDA approved a controversial drug to treat Alzheimer’s disease, Congress is attempting to amend the accelerated process that led to its approval and also the approval of many cancer drugs that have not been proven to work.
Read More »